Spritam

Drug Details

Levetiracetam, marketed under the brand name Spritam, is an antiepileptic medication used alongside other treatments to manage seizures in both adults and children. It is approved by the FDA for various types of seizures, including partial-onset seizures in individuals aged 4 years and older who weigh more than 44 pounds. It is also used as an add-on treatment for myoclonic seizures from juvenile myoclonic epilepsy in those 12 years and older, and for generalized tonic-clonic seizures in individuals 6 years and older. The exact mechanism of levetiracetam is not fully understood, but it is believed to work by inhibiting the release of certain chemicals in the brain, thereby stabilizing brain activity and reducing the occurrence of seizures. Spritam is available as a tablet for suspension, which can be taken by placing it on the tongue to dissolve or by mixing it with a small amount of liquid. It is usually administered twice daily. Common side effects of this medication include weakness, drowsiness, and headache. Currently, there is no generic version of Spritam available. It is crucial to consult with a healthcare professional before starting or adjusting any medication regimen.